[1]
|
Fuster, V. (2009) The CVD Paradox: Morality vs. Prevalence. Nature Reviews Cardiology, 6, 669. https://doi.org/10.1038/nrcardio.2009.187
|
[2]
|
Nissen, S.E., Nicholls, S.J., Sipahi, I., Libby, P., Raichlen, J.S., Ballantyne, C.M., et al. for the ASTEROID Investigators (2006) Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis—The ASTEROID Trial. JAMA, 295, 1556-1565. https://doi.org/10.1001/jama.295.13.jpc60002
|
[3]
|
Baker, J.L., Olsen, L.W. and Sorensen, T.I.A. (2007) Childhood Body-Mass Index and the Risk of Coronary Heart Disease in Adulthood. New England Journal of Medicine, 357, 2329-2337. https://doi.org/10.1056/NEJMoa072515
|
[4]
|
Ohlsson, C., Bygdell, M., Sonden, A., Rosengren, A. and Kindblom, J.M. (2016) Association between Excessive BMI Increase during Puberty and Risk of Cardiovascular Mortality in Adult Men: A Population-Based Cohort Study. Lancet, 4, 1017-1024.
|
[5]
|
Bacha, F., Edmundowicz, D., Sutton-Tyrell, K., Lee, S., Fjayli, H. and Arslanian, S.A. (2014) Coronary Artery Calcification in Obese Youth: What Are the Phenotypic and Metabolic Determinants? Diabetes Care, 37, 2632-2639.
https://doi.org/10.2337/dc14-0193
|
[6]
|
Napoli, C., Glass, C.K., Witztum, J.L., Deutsch, R., D’Armiento, F.P. and Palinski, W. (1999) Influence of Maternal Hypercholesterolaemia during Pregnancy on Progression of Early Atherosclerotic Lesions in Childhood: Fate of Early Lesions in Children (FELIC) Study. Lancet, 354, 1234-1241.
https://doi.org/10.1016/S0140-6736(99)02131-5
|
[7]
|
Napoli, C., D’Armiento, F.P., Mancini, F.P., Postiglione, A., Witztum, J.L., Palumbo, G., et al. (1997) Fatty Streak Formation Occurs in Human Fetal Aortas and Is Greatly Enhanced by Maternal Hypercholesterolemia: Intimal Accumulation of Low Density Lipoprotein and Its Oxidation Precede Monocyte Recruitment into Early Atherosclerotic Lesions. Journal of Clinical Investigation, 100, 2680-2690.
https://doi.org/10.1172/JCI119813
|
[8]
|
Stary, H.C. (1989) Evolution and Progression of Atherosclerotic Lesions in Coronary Arteries of Children and Young Adults. Arteriosclerosis, 9, 119-132.
|
[9]
|
Zhang, Z.M., Rautaharju, P.M., Prineas, R.J., Rodriguez, C.J., Loehr, L., Rosamond, W.D., et al. (2016) Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 133, 2141-2148.
https://doi.org/10.1161/CIRCULATIONAHA.115.021177
|
[10]
|
Xu, J., Murphy, S.L., Kochanek, K.D. and Arias, E. (2016) Mortality in the United States, 2015. NCHS Data Brief, 267, 1-8.
|
[11]
|
Gode, P., Vedel, P., Larsen, N., Jensen, G.V.H., Parving, H.H. and Pedersen, O. (2003) Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. The New England Journal of Medicine, 348, 383-393.
https://doi.org/10.1056/NEJMoa021778
|
[12]
|
Berry, J.D., Dyer, A., Cai, X., Garside, D.B., Ning, H., Thomas, A., et al. (2012) Lifetime Risks of Cardiovascular Disease. The New England Journal of Medicine, 366, 321-329. https://doi.org/10.1056/NEJMoa1012848
|
[13]
|
Deshmukh-Taskar, P., Nicklas, T.A., Morales, M., Yang, S.J., Zakeri, I. and Berenson, G.S. (2006) Tracking of Overweight Status from Childhood to Young Adulthood: The Bogalusa Heart Study. European Journal of Clinical Nutrition, 60, 48-57.
https://doi.org/10.1038/sj.ejcn.1602266
|
[14]
|
Srinivasan, S.R., Wattigney, W., Webber, L.S. and Berenson, G.S. (1991) Race and Gender Differences in Serum Lipoproteins of Children, Adolescents, and Young Adults—Emergence of an Adverse Lipoprotein Pattern in White Males: The Bogalusa heart study. Preventive Medicine, 20, 671-684.
https://doi.org/10.1016/0091-7435(91)90063-A
|
[15]
|
Bao, W., Srinivasan, S.R., Wattigney, W.A., Bao, W. and Berenson, G.S. (1996) Usefulness of Childhood Low-Density Lipoprotein Cholesterol Level in Predicting Adult Dyslipidemia and Other Cardiovascular Risks: The Bogalusa Heart Study. Archives of Internal Medicine, 156, 1315-1320.
https://doi.org/10.1001/archinte.1996.00440110083011
|
[16]
|
Li, S., Chen, W., Srinivasan, S.R., Bond, M.G., Tang, R. and Urbina, E.M. (2003) Childhood Cardiovascular Risk Factors and Carotid Vascular Changes in Adulthood: The Bogalusa Heart Study. JAMA, 290, 2271-2276.
https://doi.org/10.1001/jama.290.17.2271
|
[17]
|
Berenson, G.S., Wattigney, W.A., Tracy, R.E., Newman, W.P., Srinivasan, S.R., Webber, L.S., et al. (1992) Atherosclerosis of the Aorta and Coronary Arteries and Cardiovascular Risk Factors in Persons Aged 6 to 30 Years and Studied at Necropsy (The Bogalusa Heart Study). American Journal of Cardiology, 70, 851-858.
https://doi.org/10.1016/0002-9149(92)90726-F
|
[18]
|
McMahan, C.A., Gidding, S.S., Malcom, G.T., Tracy, R.E., Strong, J.P., McGill Jr., H.C., et al. (2006) Pathobiological Determinants of Atherosclerosis in Youth Risk Scores Are Associated with Early and Advanced Atherosclerosis. Pediatrics, 118, 1447-1455. https://doi.org/10.1542/peds.2006-0970
|
[19]
|
Zoler, M.L. (2016) Internal Medicine News.
https://www.mdedge.com/internalmedicinenews/article/113821/cardiology/escs-new-lipid-guidelines-keep-ldl-cholesterol
|
[20]
|
O’Keefe Jr., J.H. (2004) Optimal Low-Density Lipoprotein is 50 to 70 mg/dl: Lower Is Better and Physiologically Normal. Journal of the American College of Cardiology, 43, 2142-2146. https://doi.org/10.1016/j.jacc.2004.03.046
|
[21]
|
Gidding, S.S., Daniels, S.R. and Kavey, R.E. (2012) Expert Panel on Cardiovascular Health and Risk Reduction in Youth. Developing the 2011 Integrated Pediatric Guidelines for Cardiovascular Risk Reduction. Pediatrics, 129, e1311-e1319.
https://doi.org/10.1542/peds.2011-2903
|
[22]
|
American Diabetes Association Editors (2017) American Diabetes Association: Standards of Medical Care in Diabetes-2017. Diabetes Care, 40, S4-S5.
https://doi.org/10.2337/dc17-S003
|
[23]
|
Wikipedia Editors. Cholesterol.
https://en.wikipedia.org/wiki/cholesterol#biosynthesis
|
[24]
|
Santini, S.A., Carrozza, C., Lulli, P., Zuppi, C., CarloTonolo, G. and Musumeci, S. (2003) Atorvastatin Does Not Affect Gonadal or Adrenal Hormones in Type 2 Diabetes with Mild to Moderate Hypercholesterolemia. Journal of Atherosclerosis and Thrombosis, 10, 160-164.
|
[25]
|
Cholesterol Treatment Trialists’ (CTT) Collaboration (2010) Efficacy and Safety of More Intensive Lowering of LDL Cholesterol: A Meta-Analysis of Data from 170,000 Participants in 26 Randomised Trials. The Lancet, 376, 1670-1681.
https://doi.org/10.1016/S0140-6736(10)61350-5
|
[26]
|
Wiviott, S.D., Cannon, C.P., Morrow, D.A., Ray, K.K., Pfeffer, M.A., Braunwald, E. for the PROVE-IT-TIMI 22 Investigators (2005) Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-density Lipoprotein with Intensive Statin Therapy—A PROVE IT-TIMI 22 Substudy. Journal of the American College of Cardiology, 46, 1411-1416.
https://doi.org/10.1016/j.jacc.2005.04.064
|
[27]
|
Ray, K.K., Ginsberg, H.N., Davidson, M.H., Pordy, R., Bessac, L., Minini, P., et al. (2016) Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab with Control. Circulation, 134, 1931-1943. https://doi.org/10.1161/CIRCULATIONAHA.116.024604
|
[28]
|
McMurry, M.P., Connor, W.E. and Cerqueira, M.T. (1982) Dietary Cholesterol and the Plasma Lipids and Lipoproteins in the Tarahumara Indians: A People Habituated to a Low Cholesterol Diet after Weaning. The American Journal of Clinical Nutrition, 35, 741-744. https://doi.org/10.1093/ajcn/35.4.741
|
[29]
|
Ference, B.A., Majeed, F., Penumetcha, R., Flack, J.M. and Brook, R.D. (2015) Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both: A 2 x 2 Factorial Mendelian Randomization Study. Journal of the American College of Cardiology, 65, 1552-1561.
https://doi.org/10.1016/j.jacc.2015.02.020
|
[30]
|
Zhao, Z., Tuakli-Wosornu, Y., Lagace, T.A., Kinch, L., Grishin, N.V., Horton, J.D., et al. (2006) Molecular Characterization of Loss-of-Function Mutations in PCSK9 and Identification of a Compound Heterozygote. The American Journal of Human Genetics, 79, 514-523. https://doi.org/10.1086/507488
|
[31]
|
Raal, F.J., Pilcher, G.J., Panz, V.R., van Deventer, H.E., Brice, B.C., Blom, D.J., et al. (2011) Reduction in Mortality in Subjects with Homozygous Familial Hypercholesterolemia Associated with Advances in Lipid-lowering Therapy. Circulation, 124, 2202-2207. https://doi.org/10.1161/CIRCULATIONAHA.111.042523
|
[32]
|
Sachdeva, A., Cannon, C.P., Deedwania, P.C., Labresh, K.A., Smith Jr., S.C., Dai, D., et al. (2009) Lipid Levels in Patients Hospitalized with Coronary Artery Disease: An Analysis of 136,905 Hospitalizations in Get with the Guidelines. American Heart Journal, 159, 111-117. https://doi.org/10.1016/j.ahj.2008.08.010
|
[33]
|
Kavey, R.E., Daniels, S.R., Lauer, R.M., Atkins, D.L., Hayman, L.L. and Taubert, K. (2003) American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood. Circulation, 107, 1562-1566. https://doi.org/10.1161/01.CIR.0000061521.15730.6E
|
[34]
|
Carr, B.R., MacDonald, P.C. and Simpson, E.R. (1980) The Regulation of De Novo Synthesis of Cholesterol in the Human Fetal Adrenal Gland by Low Density Lipoprotein and Adrenocorticotropin. Endocrinology, 107, 1000-1006.
https://doi.org/10.1210/endo-107-4-1000
|
[35]
|
Carr, B.R., Parker Jr., C.R., Milewich, L., Porter, J.C., MacDonald, P.C. and Simpson, E.R. (1980) The Role of Low Density, High Density, and Very Low Density Lipoproteins in Steroidogenesis by the Human Fetal Adrenal Gland. Endocrinology, 106, 1854-1860. https://doi.org/10.1210/endo-106-6-1854
|
[36]
|
Nissen, S.E., Tsunoda, T., Tuzcu, E.M., Schoenhagen, P., Cooper, C.J., Yasin, M., et al. (2003) Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients with Acute Coronary Syndromes. JAMA, 290, 2292-2300.
https://doi.org/10.1001/jama.290.17.2292
|
[37]
|
Castelli, W.P. (1986) The Triglyceride Issue: A View from Framingham. American Heart Journal, 112, 432-437. https://doi.org/10.1016/0002-8703(86)90296-6
|
[38]
|
Libby, P. (2002) Atherosclerosis: The New View. Scientific American, 286, 46-55.
https://doi.org/10.1038/scientificamerican0502-46
|
[39]
|
Landmesser, U., Hornig, B. and Drexler, H. (2004) Endothelial Function: A Critical Determinant in Atherosclerosis? Circulation, 109, II-27-II-33.
https://doi.org/10.1161/01.CIR.0000129501.88485.1f
|
[40]
|
Ridker, P.M., Rifai, N., Pfeffer, M.A., Sacks, F.M., Moye, L.A. and Goldman, S. (1998) Inflammation, Pravastatin, and the Risk of Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels. Circulation, 98, 839-844.
https://doi.org/10.1161/01.CIR.98.9.839
|
[41]
|
Rohatgi, A., Khera, A., Berry, J.D., Givens, E.G., Ayers, C.R., Wedin, K.E., et al. (2014) HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events. The New England Journal of Medicine, 371, 2383-2393.
https://doi.org/10.1056/NEJMoa1409065
|
[42]
|
Nagano, Y., Arai, H. and Kita, T. (1991) High Density Lipoprotein Loses Its Effect to Stimulate Efflux of Cholesterol from Foam Cells after Oxidative Modification (Atherosclerosis/Regression/Macrophage). Proceedings of the National Academy of Sciences of the United States of America, 88, 6457-6461.
https://doi.org/10.1073/pnas.88.15.6457
|
[43]
|
AIM-HIGH Investigators (2011) Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy. The New England Journal of Medicine, 365, 2255-2267. https://doi.org/10.1056/NEJMoa1107579
|
[44]
|
Schade, D.S., Cavanaugh, B., Ramo, B. and Eaton, R.P. (2016) The Application of the LDL Principle. World Journal of Cardiovascular Diseases, 6, 109-125.
https://doi.org/10.4236/wjcd.2016.65012
|
[45]
|
Daniels, S.R. (2001) Cardiovascular Disease Risk Factors and Atherosclerosis in Children and Adolescents. Current Atherosclerosis Reports, 3, 479-485.
https://doi.org/10.1007/s11883-001-0038-3
|
[46]
|
Twig, G., Yaniv, G., Levine, H., Leiba, A., Goldberger, N., Derazne, E., et al. (2016) Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood. The New England Journal of Medicine, 374, 2430-2440.
https://doi.org/10.1056/NEJMoa1503840
|
[47]
|
Gidding, S.S. (2016) Why Cholesterol Testing in Children and Adolescents Matters. JAMA Cardiology, 1, 859-861. https://doi.org/10.1001/jamacardio.2016.2871
|
[48]
|
Daniels, S.R., Greer, F.R. and Committee on Nutrition (2008) Lipid Screening and Cardiovascular Health in Childhood. Pediatrics, 122, 198-208.
https://doi.org/10.1542/peds.2008-1349
|
[49]
|
Alonso, R., Andres, E., Mata, N., Fuentes-Jimenez, F., Badimon, L., Lopez-Miranda, J., et al. (2014) Lipoprotein(a) Levels in Familial Hypercholesterolemia. Journal of the American College of Cardiology, 63, 1982-1989.
https://doi.org/10.1016/j.jacc.2014.01.063
|
[50]
|
Kullo, D.K. (2009) Evolutionary Genetics of Coronary Heart Disease. Circulation, 19, 459-467.
|
[51]
|
O’Leary, D.H. and Polak, J.F. (2002) Intima-Media Thickness: A Tool for Atherosclerosis Imaging and Event Prediction. American Journal of Cardiology, 90, 18L-21L. https://doi.org/10.1016/S0002-9149(02)02957-0
|
[52]
|
Sorof, J.M., Alexandrov, A.V., Cardwell, G. and Portman, R.J. (2003) Carotid Artery Intimal-Medial Thickness and Left Ventricular Hypertrophy in Children with Elevated Blood Pressure. Pediatrics, 111, 61-66. https://doi.org/10.1542/peds.111.1.61
|
[53]
|
Wilson, P.W.F., Hoeg, J.M., D’Agostino, R.B., Silbershatz, H., Belanger, A.M., Poehlmann, H., et al. (1997) Cumulative Effects of High Cholesterol Levels, High Blood Pressure, and Cigarette Smoking on Carotid Stenosis. The New England Journal of Medicine, 337, 516-522. https://doi.org/10.1056/NEJM199708213370802
|
[54]
|
Eaton, R.P., Burge, M.R., Comerci, G., Cavanaugh, B., Ramo, B. and Schade, D.S. (2017) Abnormal Coronary Artery Calcium Scans in Asymptomatic Patients. American Journal of Medicine, 130, 394-397.
https://doi.org/10.1016/j.amjmed.2016.10.006
|
[55]
|
Urbina, E.M., Williams, R.V., Alpert, B.S., Collins, R.T., Daniels, S.R., Hayman, L., et al. (2009) Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research: A Scientific Statement from the American Heart Association. Hypertension, 54, 919-950. https://doi.org/10.1161/HYPERTENSIONAHA.109.192639
|
[56]
|
Morrison, K.M., Dyal, L., Conner, W., Helden, E., Newkirk, L., Yusuf, S., et al. (2010) Cardiovascular Risk Factors and Non-invasive Assessment of Subclinical Atherosclerosis in Youth. Atherosclerosis, 208, 501-505.
https://doi.org/10.1016/j.atherosclerosis.2009.07.034
|
[57]
|
Hu, F.B. and Willett, W.C. (2002) Optimal Diets for Prevention of Coronary Heart Disease. JAMA, 288, 2569-2578. https://doi.org/10.1001/jama.288.20.2569
|
[58]
|
Kusters, D.M., Avis, H.J., de Groot, E., Wijburg, F.A., Kastelein, J.J., Wiegman, A., et al. (2014) Ten-Year Follow-Up after Initiation of Statin Therapy in Children with Familial Hypercholesterolemia. JAMA, 312, 1055-1057.
https://doi.org/10.1001/jama.2014.8892
|
[59]
|
Braamskamp, M.J.A.M., Kastelein, J.J.P., Kusers, D.M., Hutten, B.A. and Wiegman, A. (2016) Statin Initiation during Childhood in Patients with Familial Hypercholesterolemia: Consequences for Cardiovascular Risk. Journal of the American College of Cardiology, 67, 455-456. https://doi.org/10.1016/j.jacc.2015.11.021
|
[60]
|
Franc, S., Dejager, S., Bruckert, E., Chauvenet, M., Giral, P. and Turpin, G. (2003) A Comprehensive Description of Muscle Symptoms Associated with Lipid-Lowering Drugs. Cardiovascular Drugs and Therapy, 17, 459-465.
https://doi.org/10.1023/B:CARD.0000015861.26111.ab
|
[61]
|
Sattar, N., Preiss, D., Murray, H.M., Welsh, P., Buckley, B.M., de Craen, A.J., et al. (2010) Statins and Risk of Incident Diabetes: A Collaborative Meta-Analysis of Randomized Statin Trials. The Lancet, 375, 735-742.
https://doi.org/10.1016/S0140-6736(09)61965-6
|
[62]
|
Clauss, S., Wai, K.M., Kavey, W. and Kuehl, K. (2009) Ezetimibe Treatment of Pediatric Patients with Hypercholesterolemia. Journal of Pediatrics, 154, 869-872.
https://doi.org/10.1016/j.jpeds.2008.12.044
|
[63]
|
Sudhop, T. (2002) Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans. Circulation, 106, 1943-1948.
https://doi.org/10.1161/01.CIR.0000034044.95911.DC
|
[64]
|
Selvin, E., Steffes, M.W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., et al. (2010) Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults. The New England Journal of Medicine, 362, 800-811.
https://doi.org/10.1056/NEJMoa0908359
|
[65]
|
Wadwa, R.P., Kinney, G.L., Maahs, D.M., Snell-Bergeon, J., Hokanson, J.E., Garg, S.K., et al. (2005) Awareness and Treatment of Dyslipidemia in Young Adults with Type 1 Diabetes. Diabetes Care, 28, 1051-1056.
https://doi.org/10.2337/diacare.28.5.1051
|
[66]
|
Shepherd, J., Barter, P., Carmena, R., Deedwania, P., Fruchart, J.C., Haffner, S., et al. (2006) Effect of Lowering LDL Cholesterol Substantially below Currently Recommended Levels in Patients with Coronary Heart Disease and Diabetes. Diabetes Care, 29, 1220-1226. https://doi.org/10.2337/dc05-2465
|
[67]
|
Tirosh, A., Shai, I., Afek, A., Dubnov-Raz, G., Ayalon, N., Gordon, B., et al. (2011) Adolescent BMI Trajectory and Risk of Diabetes versus Coronary Disease. The New England Journal of Medicine, 364, 1315-1325.
https://doi.org/10.1056/NEJMoa1006992
|
[68]
|
Ference, B.A., Yoo, W., Alesh, I., Mahajan, N., Mirowska, K.K., Mewada, A., et al. (2012) Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease: A Mendelian Randomization Analysis. Journal of the American College of Cardiology, 60, 2631-2639. https://doi.org/10.1016/j.jacc.2012.09.017
|
[69]
|
Strong, J.P., Malcom, G.T., McMahan, C.A., Tracy, R.E., Newman, W.P., Herderick, E.E., et al. (1999) Prevalence and Extent of Atherosclerosis in Adolescents and Young Adults: Implications for Prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA, 281, 727-735.
https://doi.org/10.1001/jama.281.8.727
|